<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="EN" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Clin Pharmacol</journal-id><journal-id journal-id-type="pmc-domain-id">279</journal-id><journal-id journal-id-type="pmc-domain">brjclinpharm</journal-id><journal-id journal-id-type="publisher-id">bcp</journal-id><journal-title-group><journal-title>British Journal of Clinical Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0306-5251</issn><issn pub-type="epub">1365-2125</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC1874430</article-id><article-id pub-id-type="pmcid-ver">PMC1874430.1</article-id><article-id pub-id-type="pmcaid">1874430</article-id><article-id pub-id-type="pmcaiid">1874430</article-id><article-id pub-id-type="pmid">12236854</article-id><article-id pub-id-type="doi">10.1046/j.1365-2125.2002.01637.x</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Therapeutics</subject></subj-group></article-categories><title-group><article-title>Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Schlienger</surname><given-names initials="RG">Raymond G</given-names></name><xref rid="au1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jick</surname><given-names initials="H">Hershel</given-names></name><xref rid="au2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meier</surname><given-names initials="CR">Christoph R</given-names></name><xref rid="au1" ref-type="aff">1</xref><xref rid="au2" ref-type="aff">2</xref></contrib><aff id="au1"><label>1</label><institution>Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital</institution><addr-line>Basel, Switzerland</addr-line></aff><aff id="au2"><label>2</label><institution>Boston Collaborative Drug Surveillance Program, Boston University Medical Center</institution><addr-line>Lexington, MA, USA</addr-line></aff></contrib-group><author-notes><corresp id="cor1">Correspondence: Christoph R. Meier, PhD, M.Sc., Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital of Basel, Petersgraben 4, CH &#8722;4031 Basel, Switzerland. Tel: + 41 61 265 88 70; Fax: + 41 61 265 88 64; E-mail: <email>Christoph.Meier@unibas.ch</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2002</year></pub-date><volume>54</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">144391</issue-id><fpage>327</fpage><lpage>332</lpage><history><date date-type="received"><day>03</day><month>12</month><year>2001</year></date><date date-type="accepted"><day>03</day><month>5</month><year>2002</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2003</year></date></event><event event-type="pmc-live"><date><day>14</day><month>01</month><year>2008</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2010-12-24 09:43:56.250"><day>24</day><month>12</month><year>2010</year></date></event></pub-history><permissions><copyright-statement>&#169; 2002 Blackwell Science Ltd</copyright-statement><copyright-year>2002</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="bcp0054-0327.pdf"/><abstract><sec><title>Aims</title><p>Aspirin decreases the risk of clinical manifestations of atherothrombosis. This effect is mainly due to inhibition of platelet aggregation and potentially due to anti-inflammatory properties of aspirin. To evaluate whether use of non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) may also be associated with a decreased risk of first-time acute myocardial infarction (AMI), we performed a population-based case-control analysis using the United Kingdom-based General Practice Research Database (GPRD)</p></sec><sec sec-type="methods"><title>Methods</title><p>We identified first-time AMI-patients free of preexisting diagnosed cardiovascular or metabolic diseases. We compared use of NSAIDs prior to the index date between cases and control patients who were matched to cases on age, gender, practice and calendar time.</p></sec><sec><title>Results</title><p>A total of 3319 cases (&#8804;75 years) with a diagnosis of first-time AMI between 1992 and 1997 and 13139 controls (matched to cases on age, sex, general practice attended, calendar time, years of prior history in the GPRD) were included. Overall, the relative risk estimate of AMI (adjusted for smoking, body mass index, hormone replacement therapy and aspirin) in current NSAID users was 1.17 (95% CI 0.99, 1.37). Long-term current NSAID use (&#8805;30 prescriptions) yielded an adjusted odds ratio (OR) of 1.20 (95% CI 0.94, 1.55). Stratification by age (&lt;65 years <italic>vs</italic>&#8805;65 years) and sex did not materially change the results.</p></sec><sec><title>Conclusions</title><p>Our findings indicate that current NSAID exposure in patients free of diagnosed cardiovascular or metabolic conditions predisposing to cardiovascular diseases does not decrease the risk of AMI.</p></sec></abstract><kwd-group><kwd>aspirin</kwd><kwd>case-control study</kwd><kwd>inflammation</kwd><kwd>myocardial infarction</kwd><kwd>non-steroidal anti-inflammatory agents</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>